Skip to main content
Robert Ramirez, DO, Oncology, Nashville, TN, Vanderbilt University Medical Center

RobertA.RamirezDOFACP

Oncology Nashville, TN

Endocrine Cancer, Thoracic Cancer

Physician

Dr. Ramirez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ramirez's full profile

Already have an account?

Summary

  • Robert Ramirez, DO, FACP
    Dr. Robert Ramirez is a thoracic and neuroendocrine oncologist at Vanderbilt University Medical Center in Nashville, TN and Associate Professor of Medicine. He earned his medical degree from the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine. He completed an internal medicine residency at Cooper University Hospital in Camden, New Jersey. He then completed a combined hematology and medical oncology fellowship at the University of Tennessee Health Sciences Center in Memphis, Tennessee where he served as chief fellow. He is a Fellow of the American College of Physicians (FACP) and a member of American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), and the North American Neuroendocrine Tumor Society (NANETS). He is a member of the Communications Committee for the IASLC and is a member of the Nominating as well as the Scientific Review and Research Committees for NANETS.

    His clinical and research interests include neuroendocrine tumors (NETs) and lung cancer. He has a specific interest in NETs of the lung, diffuse idiopathic pulmonary neuroendocrine hyperplasia (DIPNECH) and high-grade neuroendocrine carcinomas. He is active in clinical trial design including investigator-initiated trials.

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 2005 - 2008
  • Rowan University School of Osteopathic Medicine
    Rowan University School of Osteopathic MedicineClass of 2004
  • Oakland University
    Oakland UniversityB.A., Biology, Cum Laude, 2000
  • Oakland Community College
    Oakland Community CollegeAssociate of Arts, Liberal Arts, 1999

Certifications & Licensure

  • TN State Medical License
    TN State License 2008 - 2025
  • LA State Medical License
    LA State License 2012 - 2022
  • FL State Medical License
    FL State License 2020 - 2022
  • MS State Medical License
    MS State License 2020 - 2021
  • AZ State Medical License
    AZ State License 2020 - 2020
  • AL State Medical License
    AL State License 2020 - 2020
  • NJ State Medical License
    NJ State License 2006 - 2010
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Resident/Fellow Reseach Mentor of the Year Ochsner Medical Center, 2017
  • Travel Award North American Neuroendocrine Tumor Society Annual Meeting, 2013
  • Merit Award American Society of Clinical Oncology Annual Meeting, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Liver needle biopsies are poor predictors of histologic tumor grade for midgut neuroendocrine tumors  
    Ramirez, RA, Beyer, DT, Wang, YZ, Oliva, I, Voros, B, Kokodis, I, Thiagarajan, R, Ricks, MJ, Bren-Mattison, Boudreaux, JP, Wang, YZ, Woltering, EA, Clinical Oncology Research, 1/31/2020
  • Lung cancer in HIV-infected patients and the role of targeted therapy  
    Ruiz, M, Ramirez, RA, J Community and Supportive Onc, 8/2015
  • Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: A single center experience  
    A. Chauhan, R.A. Ramirez, Lung, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The role of capecitabine/temozolomide (CAPTEM) in metastatic neuroendocrine tumors: A neuroendocrine tumor program experience.
    R.A.Ramirez, A. Chauhan, D.T. Beyer, J.P. Boudreaux, Y.Z. Wang, E.A. Woltering, 2015 North American Neuroendocrine Tumor Society Annual Meeting, Austin, TX, 1/16/2015
  • Incidence of nodal positivity in appendiceal neuroendocrine tumors and its effect on survival.
    E.A. Woltering, D.T. Beyer, R. Thiagarajan, Y.Z. Wang, R.A. Ramirez, J.P. Boudreaux, 2015 North American Neuroendocrine Tumor Society Annual Meeting, Austin, TX, 1/16/2015
  • Is surgical cytoreduction for stage IV pancreatic neuroendocrine tumors justifiable.
    Y.Z. Wang, E. McCord, M.A. Stevens, A.E. Diebold, R.A. Ramirez, J.P. Boudreaux, E.A. Woltering, 2015 North American Neuroendocrine Tumor Society Annual Meeting, Austin, TX, 1/16/2015
  • Join now to see all

Lectures

  • A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade ... 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
  • Update on the Medical Management of Neuroendocrine Tumors 
    Baton Rogue, LA, 2015; New Orleans, LA, 2015 - 1/27/2015
  • Neuroendocrine tumors of the lung 
    New Orleans, LA - 1/11/2015
  • Join now to see all

Press Mentions

  • Targeted Therapy for Neuroendocrine Tumors
    Targeted Therapy for Neuroendocrine TumorsFebruary 16th, 2023
  • New Clinician Spotlight: Robert Ramirez
    New Clinician Spotlight: Robert RamirezApril 5th, 2021
  • Gene Mutations Dictate Treatment in NCI Clinical Trial
    Gene Mutations Dictate Treatment in NCI Clinical TrialJuly 5th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations